Citigroup analyst Christian Wetherbee maintains CSX (NASDAQ:CSX) with a Buy and lowers the price target from $39 to $38.
Citigroup lowers CSX (NASDAQ:CSX) price target from $39 to $38 Read Post »
Argus Research analyst John Eade maintains CSX (NASDAQ:CSX) with a Buy and raises the price target from $35 to $37.
Argus Research raises CSX (NASDAQ:CSX) price target from $35 to $37 Read Post »
Keybanc analyst Sophie Karp maintains NextEra Energy (NYSE:NEE) with a Overweight and lowers the price target from $94 to $85.
Keybanc lowers NextEra Energy (NYSE:NEE) price target from $94 to $85 Read Post »
Morgan Stanley analyst David Arcaro maintains NextEra Energy (NYSE:NEE) with a Overweight and maintains $93 price target.
Morgan Stanley maintains NextEra Energy (NYSE:NEE) $93 price target Read Post »
NextEra Energy (NYSE:NEE) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.82 by 7.32 percent. This is a 8.64 percent increase over earnings of $0.81 per share from the same period last year. The company reported quarterly sales of $7.35 billion which beat the analyst consensus estimate of $6.23 billion by 17.96 percent. This is a 41.79 percent increase over sales of $5.18 billion the same period last year.
NextEra Energy (NYSE:NEE) Q2 Adj. EPS $0.88 Beats $0.82 Estimate Read Post »
Bank of America Securities analyst Sara Senatore maintains Domino’s Pizza (NYSE:DPZ) with a Buy and raises the price target from $465 to $483.
Bank of America raises Domino’s Pizza (NYSE:DPZ) price target from $465 to $483 Read Post »
Piper Sandler Raises Domino’s Pizza (NYSE:DPZ) Price Target to $409 From $349, Overweight Rating Kept。
Piper Sandler Raises Domino’s Pizza (NYSE:DPZ) Price Target to $409 From $349 Read Post »
RTX (NYSE:RTX) reported Q2 adjusted earnings of $1.29 per diluted share, up from $1.16 a year earlier. Analysts polled by Capital IQ expected $1.18. Net sales for the quarter ended June 30 were $18.32 billion, compared with $16.31 billion a year earlier. Analysts surveyed by Capital IQ estimated $17.7 billion. RTX said it now expects full-year adjusted EPS of $4.95 to $5.05, from its previous forecast of $4.90 to $5.05, and revenue of $73 billion to $74 billion, compared with the initial range of $72 billion to $73 billion. Analysts polled by Capital IQ estimate adjusted EPS of $5.02 on revenue of $72.73 billion.
RTX (NYSE:RTX) Q2 Adjusted Earnings, Net Sales Increase Read Post »
Needham analyst Ami Fadia reiterates Biogen (NASDAQ:BIIB) with a Buy and maintains $320 price target.
Needham maintains Biogen (NASDAQ:BIIB) $320 price target Read Post »
Stifel analyst Paul Matteis maintains Biogen (NASDAQ:BIIB) with a Buy and lowers the price target from $324 to $320.
Stifel lowers Biogen (NASDAQ:BIIB) price target from $324 to $320 Read Post »
Biogen (NASDAQ:BIIB) reported Q2 non-GAAP earnings of $4.02 per diluted share, down from $5.25 a year earlier. Analysts polled by Capital IQ expected $3.76. Total revenue for the quarter ended June 30 was $2.46 billion, down from $2.59 billion a year earlier. Analysts surveyed by Capital IQ expected $2.36 billion. Biogen said it continues to expect full-year 2023 adjusted EPS of $15 to $16. Analysts polled by Capital IQ are expecting adjusted EPS of $15.43. Revenue for the year is expected to decline by mid-single-digit percentage from a year earlier.
PulteGroup (NYSE:PHM) reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.51 by 19.52 percent. This is a 9.89 percent increase over earnings of $2.73 per share from the same period last year. The company reported quarterly sales of $4.19 billion which beat the analyst consensus estimate of $3.99 billion by 5.01 percent. This is a 6.72 percent increase over sales of $3.93 billion the same period last year.